To determine whether there is biased expression of TCR Vβ segments in CD4+ cells in sarcoidosis, a panel of 24 antibodies covering approximately 70% of the TCR Vβ repertoire was tested on 15 patients. The gene discussed is CD4; the disease is sarcoidosis.